FL Zhang

Dr. FL Zhang


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Technology in Cancer Research & Treatment
Verified
Journal Article
Open access
PDF file
FZFL Zhang
FL Zhang
QWQiusheng Wang
Qiusheng Wang
HLHaipeng Li
Haipeng Li
Radiotherapy plays an important role in the treatment of non-small cell lung cancer. Accurate segmentation of the gross target volume is very important for successful radiotherapy delivery. Deep learning techniques can obtain fast and accurate segmentation, which is independent of experts’ experience and saves time compared with manual delineation. In this paper, we introduce a modified version of ResNet and apply it to segment the gross target volume in computed tomography images of patients with non-small cell lung cancer. Normalization was applied to reduce the differences among images and data augmentation techniques were employed to further enrich the data of the training set. Two different residual convolutional blocks were used to efficiently extract the deep features of the computed tomography images, and the features from all levels of the ResNet were merged into a single output. This simple design achieved a fusion of deep semantic features and shallow appearance features to generate dense pixel outputs. The test loss tended to be stable after 50 training epochs, and the segmentation took 21 ms per computed tomography image. The average evaluation metrics were: Dice similarity coefficient, 0.73; Jaccard similarity coefficient, 0.68; true positive rate, 0.71; and false positive rate, 0.0012. Those results were better than those of U-Net, which was used as a benchmark. The modified ResNet directly extracted multi-scale context features from original input images. Thus, the proposed automatic segmentation method can quickly segment the gross target volume in non-small cell lung cancer cases and be applied to improve consistency in contouring.


15 March 2022 in Frontiers in Oncology
Verified
Journal Article
Open access
FZFL Zhang
FL Zhang
QWQiusheng Wang
Qiusheng Wang
AYAnning Yang
Anning Yang
NLNa Lu
Na Lu
HJHuayong Jiang
Huayong Jiang
YWYadi Wang
Yadi Wang
Purpose: To introduce an end-to-end automatic segmentation model for organs at risk (OARs) in thoracic CT images based on modified DenseNet, and reduce the workload of radiation oncologists.Materials and Methods: The computed tomography (CT) images of 36 lung cancer patients were included in this study, of which 27 patients’ images were randomly selected as the training set, 9 patients’ as the testing set. The validation set was generated by cross validation and 6 patients’ images were randomly selected from the training set during each epoch as the validation set. The autosegmentation task of the left and right lungs, spinal cord, heart, trachea and esophagus was implemented, and the whole training time was approximately 5 hours. Geometric evaluation metrics including the Dice similarity coefficient (DSC), 95% Hausdorff distance (HD95) and average surface distance (ASD), were used to assess the autosegmentation performance of OARs based on the proposed model and were compared with those based on U-Net as benchmarks. Then, two sets of treatment plans were optimized based on the manually contoured targets and OARs (Plan1), as well as the manually contours targets and the automatically contoured OARs (Plan2). Dosimetric parameters, including Dmax, Dmean and Vx, of OARs were obtained and compared.Results: The DSC, HD95 and ASD of the proposed model were better than those of U-Net. The differences in the DSC of the spinal cord and esophagus, differences in the HD95 of the spinal cord, heart, trachea and esophagus, as well as differences in the ASD of the spinal cord were statistically significant between the two models (P0.05). Moreover, compared with manual segmentation, autosegmentation significantly reduced the contouring time by nearly 40.7% (P<0.05).Conclusions: The bilateral lungs, spinal cord, heart and trachea could be accurately delineated using the proposed model in this study; however, the automatic segmentation effect of the esophagus must still be further improved. The concept of feature map reuse provides a new idea for automatic medical image segmentation.

Verified
Journal Article
Open access
PDF file
HJHuayong Jiang
Huayong Jiang
BWBin Wang
Bin Wang
FZFL Zhang
FL Zhang
YQYuanyu Qian
Yuanyu Qian
CCChia-Chen Chuang
Chia-Chen Chuang
LZLi Zuo
Li Zuo
Checkpoint kinase 2 (CHK2) and cell division cycle 25C (CDC25C) are two proteins involved in the DNA damage response pathway, playing essential roles in maintaining genome integrity. As one of the major hallmarks of abnormal cellular division, genomic instability occurs in most cancers. In this study, we identified the functional expression of pCHK2-Thr68 and pCDC25C-Ser216 in breast cancer, as well as its association with breast cancer survival. Tissue microarray analysis using immunohistochemistry was constructed to identify the expression of pCHK2-Thr68 and pCDC25C-Ser216 in 292 female breast cancer patients. The relationship among protein expression, clinicopathological factors (e.g., human epidermal growth factor receptor 2 (HER 2), tumor size, tumor-node-metastasis (TNM) classification), and overall survival of the breast cancer tissues were analyzed using Pearson’s χ-square (χ2) test, Fisher’s exact test, multivariate logistic regression and Kaplan–Meier survival analysis. Significantly higher expressions of pCHK2-Thr68 and pCDC25C-Ser216 were observed in the nucleus of the breast cancer cells compared to the paracancerous tissue (pCHK2-Thr68, 20.38% vs. 0%; pCDC25C-Ser216, 82.26% vs. 24.24%). The expression of pCHK2-Thr68 and pCDC25C-Ser216 in breast cancer showed a positive linear correlation (p = 0.026). High expression of pCHK2-Thr68 was associated with decreased patient survival (p = 0.001), but was not an independent prognostic factor. Our results suggest that pCHK2-Thr68 and pCDC25C-Ser216 play important roles in breast cancer and may be potential treatment targets.

20 November 2025 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
YLYongxin Liu
Yongxin Liu
YPYuteng Pan
Yuteng Pan
QWQiusheng Wang
Qiusheng Wang
HJHuayong Jiang
Huayong Jiang
NLNa Lu
Na Lu
FZFL Zhang
FL Zhang
Background: Prognostic assessment of non-small cell lung cancer (NSCLC) relies on TNM staging, yet tumor heterogeneity limits its accuracy. This study aimed to develop a model for improving the prediction of overall survival (OS) in NSCLC patients receiving radiotherapy, which integrated intratumoral/peritumoral radiomics features and 3D deep learning (DL) features. Methods: A total of 303 NSCLC patients from three centers were retrospectively enrolled. Radiomics features were extracted from intratumoral and 3/6/9 mm peritumoral regions on CT scans. A network named 3D-SE-ResNet was proposed to extract DL features. Lasso-Cox and principal component analysis (PCA) were used to integrate multidimensional features to establish a combined model. Performance was evaluated via the concordance index (C-index) and area under the curve (AUC). Survival differences were visualized through Kaplan–Meier curves. Results: The 6 mm expansion peritumoral radiomics features analysis showed the best performance (C-index: 0.63). The DL features outperformed the radiomics features (C-index: 0.74 vs 0.63). The combined model achieved the highest accuracy (C-index: 0.77/0.73 across datasets). K–M analysis confirmed significant survival differences (log-rank P < 0.001). Conclusion: The combined model integrates intratumoral/peritumoral radiomics features and 3D DL features and effectively predicts the OS of NSCLC patients, offering a novel tool for personalized radiotherapy strategies.

1 August 2016 in Oncology and Translational Medicine
Verified
Journal Article
Closed access
FZFL Zhang
FL Zhang
HJHuayong Jiang
Huayong Jiang
WXWeidong Xu
Weidong Xu
YWYadi Wang
Yadi Wang
JGJunmao Gao
Junmao Gao
JCJianping Chen
Jianping Chen
Objective: The aim of the study was to compare flattening filter-free (FFF) beams and conventional flattening filter (FF) beams in volumetric modulated arc therapy (VMAT) for cervical cancer after surgery, through a retrospective planning study. Methods: VMAT plans of FFF beams and normal FF beams were designed for a cohort of 15 patients. The prescribed dose was 45 Gy to 1.8 Gy per fraction, and at least 95% of the planning target volume received this dose. Doses were computed with a commercially available treatment planning system using a Monte Carlo (MC) algorithm. Plans were compared according to dose-volume histogram analysis in terms of planning target volume homogeneity and conformity indices (HI and CI), as well as organs at risk (OAR) dose and volume parameters. Results: FFF-VMAT was similar to FF-VMAT in terms of CI, but inferior to FF-VMAT considering HI. No statistically differences were observed between FFF-VMAT and FF-VMAT in following organ at risks including pelvic bone marrow, small bowel, bladder, rectum, and normal tissue (NT). . Conclusion: For patients with cervical cancer after hysterectomy, the FFF beam achieved target and OAR dose distribution similar to that of the FF beam. Reduction of beam-on time in cervical cancer is beneficial.